Serine proteases of the human immune system in health and disease

Molecular Immunology

Volumn 47, Issue 11-12, 2010, Pages 1943-1955

  Heutinck, Kirstin M ^a   ten Berge, Ineke J M ^a   Hack, C Erik ^b   Hamann, Jörg ^a   Rowshani, Ajda T ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Apoptosis; Cancer; Granzymes; Immunity; Immunological disorders; Inflammation; Mast cells; Neutrophils; Serine protease; Serpins

Indexed keywords

ALPHA 1 ANTITRYPSIN; CATHEPSIN G; CHYMASE; GRANZYME; LEUKOCYTE ELASTASE; MYELOBLASTIN; PARVOVIRUS VECTOR; PROTEINASE INHIBITOR; SERINE PROTEINASE; SERINE PROTEINASE INHIBITOR; TRYPTASE; TRYPTASE INHIBITOR;

ADAPTIVE IMMUNITY; APOPTOSIS; BLOOD CLOTTING; CLINICAL TRIAL; CYSTIC FIBROSIS; CYTOTOXIC LYMPHOCYTE; EMPHYSEMA; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; EXTRACELLULAR MATRIX; HOST RESISTANCE; HUMAN; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; IMMUNOPATHOLOGY; INFLAMMATION; MAST CELL; MOLECULAR MECHANICS; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVIEW; TISSUE REPAIR; VIRUS CELL INTERACTION;

APOPTOSIS; BLOOD COAGULATION; GRANZYMES; HUMANS; IMMUNE SYSTEM; INFLAMMATION; MAST CELLS; NEUTROPHILS; SERINE PROTEASES;

EID: 77953609646     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2010.04.020     Document Type: Review

References (163)

1. Alberts B., Johnson A., Lewis J., Raff M., Roberts K., Walter P. Cell Junctions, Cell Adhesion, and the Extracellular Matrix, Molecular biology of the cell 2002, Garland Science, New York.
2. Andrade F., Fellows E., Jenne D.E., Rosen A., Young C.S. Granzyme H destroys the function of critical adenoviral proteins required for viral DNA replication and granzyme B inhibition. EMBO J. 2007, 26:2148-2157.
3. Ariel A., Yavin E.J., Hershkoviz R., Avron A., Franitza S., Hardan I., Cahalon L., Fridkin M., Lider O. IL-2 induces T cell adherence to extracellular matrix: inhibition of adherence and migration by IL-2 peptides generated by leukocyte elastase. J. Immunol. 1998, 161:2465-2472.
4. Bade B., Boettcher H.E., Lohrmann J., Hink-Schauer C., Bratke K., Jenne D.E., Virchow J.C., Luttmann W. Differential expression of the granzymes A, K and M and perforin in human peripheral blood lymphocytes. Int. Immunol. 2005, 17:1419-1428.
5. Bade B., Lohrmann J., ten B.A., Wolbink A.M., Wolbink G.J., ten Berge I.J.M., Virchow J.C., Luttmann W., Hack C.E. Detection of soluble human granzyme K in vitro and in vivo. Eur. J. Immunol. 2005, 35:2940-2948.
6. Berger P., Tunon-De-Lara J.M., Savineau J.P., Marthan R. Selected contribution: tryptase-induced PAR-2-mediated Ca(2+) signaling in human airway smooth muscle cells. J. Appl. Physiol. 2001, 91:995-1003.
7. Bird P.I., Trapani J.A., Villadangos J.A. Endolysosomal proteases and their inhibitors in immunity. Nat. Rev. Immunol. 2009, 9:871-882.
8. Bladergroen B.A., Strik M.C., Wolbink A.M., Wouters D., Broekhuizen R., Kummer J.A., Hack C.E. The granzyme B inhibitor proteinase inhibitor 9 (PI9) is expressed by human mast cells. Eur. J. Immunol. 2005, 35:1175-1183.
9. Blank U., Essig M., Scandiuzzi L., Benhamou M., Kanamaru Y. Mast cells and inflammatory kidney disease. Immunol. Rev. 2007, 217:79-95.
10. Bots M., de Bruin E., Rademaker-Koot M.T., Medema J.P. Proteinase inhibitor-9 expression is induced by maturation in dendritic cells via p38 MAP kinase. Hum. Immunol. 2007, 68:959-964.
11. Bots M., Medema J.P. Serpins in T cell immunity. J. Leukoc. Biol. 2008, 84:1238-1247.
12. Bots M., van Bostelen L., Rademaker M.T., Offringa R., Medema J.P. Serpins prevent granzyme-induced death in a species-specific manner. Immunol. Cell Biol. 2006, 84:79-86.
13. Bovenschen N., de Koning P.J., Quadir R., Broekhuizen R., Damen J.M., Froelich C.J., Slijper M., Kummer J.A. NK cell protease granzyme M targets alpha-tubulin and disorganizes the microtubule network. J. Immunol. 2008, 180:8184-8191.
14. Bovenschen N., Quadir R., van den Berg A.L., Brenkman A.B., Vandenberghe I., Devreese B., Joore J., Kummer J.A. Granzyme K displays highly restricted substrate specificity that only partially overlaps with granzyme A. J. Biol. Chem. 2009, 284:3504-3512.
15. Brantly M.L., Chulay J.D., Wang L., Mueller C., Humphries M., Spencer L.T., Rouhani F., Conlon T.J., Calcedo R., Betts M.R., Spencer C., Byrne B.J., Wilson J.M., Flotte T.R. Sustained transgene expression despite T lymphocyte responses in a clinical trial of rAAV1-AAT gene therapy. Proc. Natl. Acad. Sci. U.S.A 2009, 106:16363-16368.
16. Bratke K., Klug A., Julius P., Kuepper M., Lommatzsch M., Sparmann G., Luttmann W., Virchow J.C. Granzyme K: a novel mediator in acute airway inflammation. Thorax 2008, 63:1006-1011.
17. Bratke K., Kuepper M., Bade B., Virchow J.C., Luttmann W. Differential expression of human granzymes A, B, and K in natural killer cells and during CD8+ T cell differentiation in peripheral blood. Eur. J. Immunol. 2005, 35:2608-2616.
18. Bromley M., Fisher W.D., Woolley D.E. Mast cells at sites of cartilage erosion in the rheumatoid joint. Ann. Rheum. Dis. 1984, 43:76-79.
19. Buzza M.S., Hirst C.E., Bird C.H., Hosking P., McKendrick J., Bird P.I. The granzyme B inhibitor, PI-9, is present in endothelial and mesothelial cells, suggesting that it protects bystander cells during immune responses. Cell Immunol. 2001, 210:21-29.
20. Chavez-Galan L., renas-Del Angel M.C., Zenteno E., Chavez R., Lascurain R. Cell death mechanisms induced by cytotoxic lymphocytes. Cell Mol. Immunol. 2009, 6:15-25.
21. Chowdhury D., Beresford P.J., Zhu P., Zhang D., Sung J.S., Demple B., Perrino F.W., Lieberman J. The exonuclease TREX1 is in the SET complex and acts in concert with NM23-H1 to degrade DNA during granzyme A-mediated cell death. Mol. Cell 2006, 23:133-142.
22. Choy J.C., Hung V.H., Hunter A.L., Cheung P.K., Motyka B., Goping I.S., Sawchuk T., Bleackley R.C., Podor T.J., McManus B.M., Granville D.J. Granzyme B induces smooth muscle cell apoptosis in the absence of perforin: involvement of extracellular matrix degradation. Arterioscler. Thromb. Vasc. Biol. 2004, 24:2245-2250.
23. Cooley J., McDonald B., Accurso F.J., Crouch E.C., Remold-O'Donnell E. Patterns of neutrophil serine protease-dependent cleavage of surfactant protein D in inflammatory lung disease. J. Leukoc. Biol. 2008, 83:946-955.
24. Cooley J., Takayama T.K., Shapiro S.D., Schechter N.M., Remold-O'Donnell E. The serpin MNEI inhibits elastase-like and chymotrypsin-like serine proteases through efficient reactions at two active sites. Biochemistry 2001, 40:15762-15770.
25. Cullen S.P., Adrain C., Luthi A.U., Duriez P.J., Martin S.J. Human and murine granzyme B exhibit divergent substrate preferences. J. Cell Biol. 2007, 176:435-444.
26. Cullen S.P., Afonina I.S., Donadini R., Luthi A.U., Medema J.P., Bird P.I., Martin S.J. Nucleophosmin is cleaved and inactivated by the cytotoxic granule protease granzyme M during NK cell-mediated killing. J. Biol. Chem. 2008.
27. Cullen, S.P., Brunet, M., Martin, S.J., 2010. Granzymes in cancer and immunity. Cell Death. Differ.
28. Cullen S.P., Martin S.J. Mechanisms of granule-dependent killing. Cell Death. Differ. 2008, 15:251-262.
29. de Koning P.J., Tesselaar K., Bovenschen N., Colak S., Quadir R., Volman T.J., Kummer J.A. The cytotoxic protease granzyme M is expressed by lymphocytes of both the innate and adaptive immune system. Mol. Immunol. 2010, 47:903-911.
30. Dell'Italia L.J., Husain A. Dissecting the role of chymase in angiotensin II formation and heart and blood vessel diseases. Curr. Opin. Cardiol. 2002, 17:374-379.
31. Dengler R., Munstermann U., al-Batran S., Hausner I., Faderl S., Nerl C., Emmerich B. Immunocytochemical and flow cytometric detection of proteinase 3 (myeloblastin) in normal and leukaemic myeloid cells. Br. J. Haematol. 1995, 89:250-257.
32. Devaney J.M., Greene C.M., Taggart C.C., Carroll T.P., O'Neill S.J., McElvaney N.G. Neutrophil elastase up-regulates interleukin-8 via toll-like receptor 4. FEBS Lett. 2003, 544:129-132.
33. Doring G., Frank F., Boudier C., Herbert S., Fleischer B., Bellon G. Cleavage of lymphocyte surface antigens CD2, CD4, and CD8 by polymorphonuclear leukocyte elastase and cathepsin G in patients with cystic fibrosis. J. Immunol. 1995, 154:4842-4850.
34. Doucey M.A., Legler D.F., Faroudi M., Boucheron N., Baumgaertner P., Naeher D., Cebecauer M., Hudrisier D., Ruegg C., Palmer E., Valitutti S., Bron C., Luescher I.F. The beta1 and beta3 integrins promote T cell receptor-mediated cytotoxic T lymphocyte activation. J. Biol. Chem. 2003, 278:26983-26991.
35. Dublet B., Ruello A., Pederzoli M., Hajjar E., Courbebaisse M., Canteloup S., Reuter N., Witko-Sarsat V. Cleavage of p21/WAF1/CIP1 by proteinase 3 modulates differentiation of a monocytic cell line. Molecular analysis of the cleavage site. J. Biol. Chem. 2005, 280:30242-30253.
36. Dugas-Breit S., Schopf P., Dugas M., Schiffl H., Rueff F., Przybilla B. Baseline serum levels of mast cell tryptase are raised in hemodialysis patients and associated with severity of pruritus. J. Dtsch. Dermatol. Ges. 2005, 3:343-347.
37. Erin E.M., Leaker B.R., Zacharasiewicz A., Higgins L.A., Nicholson G.C., Boyce M.J., de B.P., Jones R.C., Durham S.R., Barnes P.J., Hansel T.T. Effects of a reversible beta-tryptase and trypsin inhibitor (RWJ-58643) on nasal allergic responses. Clin. Exp. Allergy 2006, 36:458-464.
38. Fajardo I., Pejler G. Formation of active monomers from tetrameric human beta-tryptase. Biochem. J. 2003, 369:603-610.
39. Fan Z., Beresford P.J., Oh D.Y., Zhang D., Lieberman J. Tumor suppressor NM23-H1 is a granzyme A-activated DNase during CTL-mediated apoptosis, and the nucleosome assembly protein SET is its inhibitor. Cell 2003, 112:659-672.
40. Fellows E., Gil-Parrado S., Jenne D.E., Kurschus F.C. Natural killer cell-derived human granzyme H induces an alternative, caspase-independent cell-death program. Blood 2007, 110:544-552.
41. Fischbach W., Becker W., Mossner J., Ohlemuller H., Koch W., Borner W. Leucocyte elastase in chronic inflammatory bowel diseases: a marker of inflammatory activity?. Digestion 1987, 37:88-95.
42. Frisch S.M., Francis H. Disruption of epithelial cell-matrix interactions induces apoptosis. J. Cell Biol. 1994, 124:619-626.
43. Froelich C.J., Pardo J., Simon M.M. Granule-associated serine proteases: granzymes might not just be killer proteases. Trends Immunol. 2009.
44. Frungieri M.B., Weidinger S., Meineke V., Kohn F.M., Mayerhofer A. Proliferative action of mast-cell tryptase is mediated by PAR2, COX2, prostaglandins, and PPARgamma: Possible relevance to human fibrotic disorders. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:15072-15077.
45. Gaafar A., Aljurf M.D., Al-Sulaiman A., Iqniebi A., Manogaran P.S., Mohamed G.E., Al-Sayed A., Alzahrani H., Alsharif F., Mohareb F., Ajarim D., Tabakhi A., Al-Hussein K. Defective gammadelta T-cell function and granzyme B gene polymorphism in a cohort of newly diagnosed breast cancer patients. Exp. Hematol. 2009, 37:838-848.
46. Geraghty P., Rogan M.P., Greene C.M., Boxio R.M., Poiriert T., O'Mahony M., Belaaouaj A., O'Neill S.J., Taggart C.C., McElvaney N.G. Neutrophil elastase up-regulates cathepsin B and matrix metalloprotease-2 expression. J. Immunol. 2007, 178:5871-5878.
47. Godal R., Keilholz U., Uharek L., Letsch A., Asemissen A.M., Busse A., Na I.K., Thiel E., Scheibenbogen C. Lymphomas are sensitive to perforin-dependent cytotoxic pathways despite expression of PI-9 and overexpression of bcl-2. Blood 2006, 107:3205-3211.
48. Goping I.S., Barry M., Liston P., Sawchuk T., Constantinescu G., Michalak K.M., Shostak I., Roberts D.L., Hunter A.M., Korneluk R., Bleackley R.C. Granzyme B-induced apoptosis requires both direct caspase activation and relief of caspase inhibition. Immunity 2003, 18:355-365.
49. Goping I.S., Sawchuk T., Underhill D.A., Bleackley R.C. Identification of {alpha}-tubulin as a granzyme B substrate during CTL-mediated apoptosis. J. Cell Sci. 2006, 119:858-865.
50. Grassi M., Capello F., Bertolino L., Seia Z., Pippione M. Identification of granzyme B-expressing CD-8-positive T cells in lymphocytic inflammatory infiltrate in cutaneous lupus erythematosus and in dermatomyositis. Clin. Exp. Dermatol. 2009.
51. Griese M., Latzin P., Kappler M., Weckerle K., Heinzlmaier T., Bernhardt T., Hartl D. alpha1-Antitrypsin inhalation reduces airway inflammation in cystic fibrosis patients. Eur. Respir. J. 2007, 29:240-250.
52. Grossman W.J., Verbsky J.W., Barchet W., Colonna M., Atkinson J.P., Ley T.J. Human T regulatory cells can use the perforin pathway to cause autologous target cell death. Immunity 2004, 21:589-601.
53. Grossman W.J., Verbsky J.W., Tollefsen B.L., Kemper C., Atkinson J.P., Ley T.J. Differential expression of granzymes A and B in human cytotoxic lymphocyte subsets and T regulatory cells. Blood 2004, 104:2840-2848.
54. Guo Y., Chen J., Zhao T., Fan Z. Granzyme K degrades the redox/DNA repair enzyme Ape1 to trigger oxidative stress of target cells leading to cytotoxicity. Mol. Immunol. 2008, 45:2225-2235.
55. Hagn M., Schwesinger E., Ebel V., Sontheimer K., Maier J., Beyer T., Syrovets T., Laumonnier Y., Fabricius D., Simmet T., Jahrsdorfer B. Human B Cells Secrete Granzyme B When Recognizing Viral Antigens in the Context of the Acute Phase Cytokine IL-21. J. Immunol. 2009, 183:1838-1845.
56. Harari A., Enders F.B., Cellerai C., Bart P.A., Pantaleo G. Distinct profiles of cytotoxic granules in memory CD8 T cells correlate with function, differentiation stage, and antigen exposure. J. Virol. 2009, 83:2862-2871.
57. Hartveit F., Thoresen S., Tangen M., Maartmann-Moe H. Mast cell changes and tumour dissemination in human breast carcinoma. Invasion Metastasis 1984, 4:146-155.
58. Hayakawa, M., Katabami, K., Wada, T., Sugano, M., Hoshino, H., Sawamura, A., Gando, S., 2009. Sivelestat (selective neutrophil elastase inhibitor) improves the mortality rate of sepsis associated with both ARDS and DIC patients. Shock.
59. He S.H. Key role of mast cells and their major secretory products in inflammatory bowel disease. World J. Gastroenterol. 2004, 10:309-318.
60. Heresi G.A., Stoller J.K. Augmentation therapy in alpha-1 antitrypsin deficiency. Expert. Opin. Biol. Ther. 2008, 8:515-526.
61. Hodge S., Hodge G., Nairn J., Holmes M., Reynolds P.N. Increased airway granzyme b and perforin in current and ex-smoking COPD subjects. COPD 2006, 3:179-187.
62. Horiuchi K., Saito S., Sasaki R., Tomatsu T., Toyama Y. Expression of granzyme B in human articular chondrocytes. J. Rheumatol. 2003, 30:1799-1810.
63. Hou Q., Zhao T., Zhang H., Lu H., Zhang Q., Sun L., Fan Z. Granzyme H induces apoptosis of target tumor cells characterized by DNA fragmentation and Bid-dependent mitochondrial damage. Mol. Immunol. 2007.
64. Hua G., Wang S., Zhong C., Xue P., Fan Z. Ignition of p53 Bomb Sensitizes Tumor Cells to Granzyme K-Mediated Cytolysis. J. Immunol. 2009, 182:2152-2159.
65. Hua G., Zhang Q., Fan Z. Heat shock protein 75 (TRAP1) antagonizes reactive oxygen species generation and protects cells from granzyme M-mediated apoptosis. J. Biol. Chem. 2007, 282:20553-20560.
66. Huang Y., de R.A., de L.L., Ghazi B., Martin-Garcia N., Travert M., Bosq J., Briere J., Petit B., Thomas E., Coppo P., Marafioti T., Emile J.F., fau-Larue M.H., Schmitt C., Gaulard P. Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type. Blood 2010, 115:1226-1237.
67. Huntington J.A., Read R.J., Carrell R.W. Structure of a serpin-protease complex shows inhibition by deformation. Nature 2000, 407:923-926.
68. Izuhara K., Ohta S., Kanaji S., Shiraishi H., Arima K. Recent progress in understanding the diversity of the human ov-serpin/clade B serpin family. Cell Mol. Life Sci. 2008, 65:2541-2553.
69. Jahrsdorfer B., Vollmer A., Blackwell S.E., Maier J., Sontheimer K., Beyer T., Mandel B., Lunov O., Tron K., Nienhaus G.U., Simmet T., Debatin K.M., Weiner G.J., Fabricius D. Granzyme B produced by human plasmacytoid dendritic cells suppresses T-cell expansion. Blood 2010, 115:1156-1165.
70. Ju M.J., Qiu S.J., Gao Q., Fan J., Cai M.Y., Li Y.W., Tang Z.Y. Combination of peritumoral mast cells and T-regulatory cells predicts prognosis of hepatocellular carcinoma. Cancer Sci. 2009, 100:1267-1274.
71. Kaiserman D., Bird C.H., Sun J., Matthews A., Ung K., Whisstock J.C., Thompson P.E., Trapani J.A., Bird P.I. The major human and mouse granzymes are structurally and functionally divergent. J. Cell Biol. 2006, 175:619-630.
72. Kaiserman, D., Bird, P.I., 2009. Control of granzymes by serpins. Cell Death. Differ.
73. Kallenberg C.G. Pathogenesis of PR3-ANCA associated vasculitis. J. Autoimmun. 2008, 30:29-36.
74. Kelly J.M., Waterhouse N.J., Cretney E., Browne K.A., Ellis S., Trapani J.A., Smyth M.J. Granzyme M mediates a novel form of perforin-dependent cell death. J. Biol. Chem. 2004, 279:22236-22242.
75. Kielty C.M., Lees M., Shuttleworth C.A., Woolley D. Catabolism of intact type VI collagen microfibrils: susceptibility to degradation by serine proteinases. Biochem. Biophys. Res. Commun. 1993, 191:1230-1236.
76. Knickelbein J.E., Khanna K.M., Yee M.B., Baty C.J., Kinchington P.R., Hendricks R.L. Noncytotoxic lytic granule-mediated CD8+ T cell inhibition of HSV-1 reactivation from neuronal latency. Science 2008, 322:268-271.
77. Kondo S., Kagami S., Kido H., Strutz F., Muller G.A., Kuroda Y. Role of mast cell tryptase in renal interstitial fibrosis. J. Am. Soc. Nephrol. 2001, 12:1668-1676.
78. Korkmaz B., Attucci S., Jourdan M.L., Juliano L., Gauthier F. Inhibition of neutrophil elastase by alpha1-protease inhibitor at the surface of human polymorphonuclear neutrophils. J. Immunol. 2005, 175:3329-3338.
79. Korkmaz B., Moreau T., Gauthier F. Neutrophil elastase, proteinase 3 and cathepsin G: physicochemical properties, activity and physiopathological functions. Biochimie 2008, 90:227-242.
80. Kovanen P.T. Mast cells: multipotent local effector cells in atherothrombosis. Immunol. Rev. 2007, 217:105-122.
81. Krenacs L., Smyth M.J., Bagdi E., Krenacs T., Kopper L., Rudiger T., Zettl A., Muller-Hermelink H.K., Jaffe E.S., Raffeld M. The serine protease granzyme M is preferentially expressed in NK-cell, gamma delta T-cell, and intestinal T-cell lymphomas: evidence of origin from lymphocytes involved in innate immunity. Blood 2003, 101:3590-3593.
82. Krishna M.T., Chauhan A., Little L., Sampson K., Hawksworth R., Mant T., Djukanovic R., Lee T., Holgate S. Inhibition of mast cell tryptase by inhaled APC 366 attenuates allergen-induced late-phase airway obstruction in asthma. J. Allergy Clin. Immunol. 2001, 107:1039-1045.
83. Kudo T., Kigoshi H., Hagiwara T., Takino T., Yamazaki M., Yui S. Cathepsin G, a neutrophil protease, induces compact cell-cell adhesion in MCF-7 human breast cancer cells. Mediators Inflamm. 2009, 2009:850940.
84. Kummer J.A., Kamp A.M., Citarella F., Horrevoets A.J., Hack C.E. Expression of human recombinant granzyme A zymogen and its activation by the cysteine proteinase cathepsin C. J. Biol. Chem. 1996, 271:9281-9286.
85. Kummer J.A., Wever P.C., Kamp A.M., ten Berge I.J.M., Hack C.E., Weening J.J. Expression of granzyme A and B proteins by cytotoxic lymphocytes involved in acute renal allograft rejection. Kidney Int. 1995, 47:70-77.
86. Laforge M., Bidere N., Carmona S., Devocelle A., Charpentier B., Senik A. Apoptotic death concurrent with CD3 stimulation in primary human CD8+ T lymphocytes: a role for endogenous granzyme B. J. Immunol. 2006, 176:3966-3977.
87. Langhorst J., Elsenbruch S., Koelzer J., Rueffer A., Michalsen A., Dobos G.J. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices. Am. J. Gastroenterol. 2008, 103:162-169.
88. Lauw F.N., Simpson A.J., Hack C.E., Prins J.M., Wolbink A.M., van Deventer S.J., Chaowagul W., White N.J., van der P.T. Soluble granzymes are released during human endotoxemia and in patients with severe infection due to gram-negative bacteria. J. Infect. Dis. 2000, 182:206-213.
89. Lazaar A.L., Plotnick M.I., Kucich U., Crichton I., Lotfi S., Das S.K., Kane S., Rosenbloom J., Panettieri R.A., Schechter N.M., Pure E. Mast cell chymase modifies cell-matrix interactions and inhibits mitogen-induced proliferation of human airway smooth muscle cells. J. Immunol. 2002, 169:1014-1020.
90. Li B., Hartono C., Ding R., Sharma V.K., Ramaswamy R., Qian B., Serur D., Mouradian J., Schwartz J.E., Suthanthiran M. Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine. N. Engl. J. Med. 2001, 344:947-954.
91. Lu H., Hou Q., Zhao T., Zhang H., Zhang Q., Wu L., Fan Z. Granzyme M directly cleaves inhibitor of caspase-activated DNase (CAD) to unleash CAD leading to DNA fragmentation. J. Immunol. 2006, 177:1171-1178.
92. Mahrus S., Kisiel W., Craik C.S. Granzyme M is a regulatory protease that inactivates proteinase inhibitor 9, an endogenous inhibitor of granzyme B. J. Biol. Chem. 2004, 279:54275-54282.
93. Mambole A., Baruch D., Nusbaum P., Bigot S., Suzuki M., Lesavre P., Fukuda M., Halbwachs-Mecarelli L. The cleavage of neutrophil leukosialin (CD43) by cathepsin G releases its extracellular domain and triggers its intramembrane proteolysis by presenilin/gamma-secretase. J. Biol. Chem. 2008, 283:23627-23635.
94. Martinvalet D., Dykxhoorn D.M., Ferrini R., Lieberman J. Granzyme A cleaves a mitochondrial complex I protein to initiate caspase-independent cell death. Cell 2008, 133:681-692.
95. Meade J.L., de Wynter E.A., Brett P., Sharif S.M., Woods C.G., Markham A.F., Cook G.P. A family with Papillon-Lefevre syndrome reveals a requirement for cathepsin C in granzyme B activation and NK cell cytolytic activity. Blood 2006, 107:3665-3668.
96. Methot N., Rubin J., Guay D., Beaulieu C., Ethier D., Reddy T.J., Riendeau D., Percival M.D. Inhibition of the activation of multiple serine proteases with a cathepsin C inhibitor requires sustained exposure to prevent pro-enzyme processing. J. Biol. Chem. 2007, 282:20836-20846.
97. Metkar S.S., Menaa C., Pardo J., Wang B., Wallich R., Freudenberg M., Kim S., Raja S.M., Shi L., Simon M.M., Froelich C.J. Human and mouse granzyme a induce a proinflammatory cytokine response. Immunity 2008, 29:720-733.
98. Mezyk-Kopec R., Bzowska M., Bzowska M., Mickowska B., Mak P., Potempa J., Bereta J. Effects of elastase and cathepsin G on the levels of membrane and soluble TNFalpha. Biol. Chem. 2005, 386:801-811.
99. Mizutani H., Schechter N., Lazarus G., Black R.A., Kupper T.S. Rapid and specific conversion of precursor interleukin 1 beta (IL-1 beta) to an active IL-1 species by human mast cell chymase. J. Exp. Med. 1991, 174:821-825.
100. Molldrem J., Dermime S., Parker K., Jiang Y.Z., Mavroudis D., Hensel N., Fukushima P., Barrett A.J. Targeted T-cell therapy for human leukemia: cytotoxic T lymphocytes specific for a peptide derived from proteinase 3 preferentially lyse human myeloid leukemia cells. Blood 1996, 88:2450-2457.
101. Morice W.G., Jevremovic D., Hanson C.A. The expression of the novel cytotoxic protein granzyme M by large granular lymphocytic leukaemias of both T-cell and NK-cell lineage: an unexpected finding with implications regarding the pathobiology of these disorders. Br. J. Haematol. 2007, 137:237-239.
102. Morris E., Hart D., Gao L., Tsallios A., Xue S.A., Stauss H. Generation of tumor-specific T-cell therapies. Blood Rev. 2006, 20:61-69.
103. Mullan C.S., Riley M., Clarke D., Tatler A., Sutcliffe A., Knox A.J., Pang L. Beta-tryptase regulates IL-8 expression in airway smooth muscle cells by a PAR-2-independent mechanism. Am. J. Respir. Cell Mol. Biol. 2008, 38:600-608.
104. Murakami M., Karnik S.S., Husain A. Human prochymase activation. A novel role for heparin in zymogen processing. J. Biol. Chem. 1995, 270:2218-2223.
105. Nakamura H., Yoshimura K., McElvaney N.G., Crystal R.G. Neutrophil elastase in respiratory epithelial lining fluid of individuals with cystic fibrosis induces interleukin-8 gene expression in a human bronchial epithelial cell line. J. Clin. Invest. 1992, 89:1478-1484.
106. Namazi M.R. Possible molecular mechanisms to account for the involvement of tryptase in the pathogenesis of psoriasis. Autoimmunity 2005, 38:449-452.
107. Nathan C. Neutrophils and immunity: challenges and opportunities. Nat. Rev. Immunol. 2006, 6:173-182.
108. Omoto Y., Tokime K., Yamanaka K., Habe K., Morioka T., Kurokawa I., Tsutsui H., Yamanishi K., Nakanishi K., Mizutani H. Human mast cell chymase cleaves pro-IL-18 and generates a novel and biologically active IL-18 fragment. J. Immunol. 2006, 177:8315-8319.
109. Owen C.A., Campbell M.A., Sannes P.L., Boukedes S.S., Campbell E.J. Cell surface-bound elastase and cathepsin G on human neutrophils: a novel, non-oxidative mechanism by which neutrophils focus and preserve catalytic activity of serine proteinases. J. Cell Biol. 1995, 131:775-789.
110. Page M.J., Di Cera E. Serine peptidases: classification, structure and function. Cell Mol. Life Sci. 2008, 65:1220-1236.
111. Pang L., Nie M., Corbett L., Sutcliffe A., Knox A.J. Mast cell beta-tryptase selectively cleaves eotaxin and RANTES and abrogates their eosinophil chemotactic activities. J. Immunol. 2006, 176:3788-3795.
112. Pao L.I., Sumaria N., Kelly J.M., van D.S., Cretney E., Wallace M.E., Anthony D.A., Uldrich A.P., Godfrey D.I., Papadimitriou J.M., Mullbacher A., gli-Esposti M.A., Smyth M.J. Functional analysis of granzyme M and its role in immunity to infection. J. Immunol. 2005, 175:3235-3243.
113. Pejler G., Abrink M., Ringvall M., Wernersson S. Mast cell proteases. Adv. Immunol. 2007, 95:167-255.
114. Prakash M.D., Bird C.H., Bird P.I. Active and zymogen forms of granzyme B are constitutively released from cytotoxic lymphocytes in the absence of target cell engagement. Immunol. Cell Biol. 2009, 87:249-254.
115. Rao R.M., Betz T.V., Lamont D.J., Kim M.B., Shaw S.K., Froio R.M., Baleux F., renzana-Seisdedos F., Alon R., Luscinskas F.W. Elastase release by transmigrating neutrophils deactivates endothelial-bound SDF-1alpha and attenuates subsequent T lymphocyte transendothelial migration. J. Exp. Med. 2004, 200:713-724.
116. Reich M., Lesner A., Legowska A., Sienczyk M., Oleksyszyn J., Boehm B.O., Burster T. Application of specific cell permeable cathepsin G inhibitors resulted in reduced antigen processing in primary dendritic cells. Mol. Immunol. 2009.
117. Roghanian A., Drost E.M., MacNee W., Howie S.E., Sallenave J.M. Inflammatory lung secretions inhibit dendritic cell maturation and function via neutrophil elastase. Am. J. Respir. Crit Care Med. 2006, 174:1189-1198.
118. Roghanian A., Sallenave J.M. Neutrophil elastase (NE) and NE inhibitors: canonical and noncanonical functions in lung chronic inflammatory diseases (cystic fibrosis and chronic obstructive pulmonary disease). J. Aerosol Med. Pulm. Drug Deliv. 2008, 21:125-144.
119. Romero V., Andrade F. Non-apoptotic functions of granzymes. Tissue Antigens 2008, 71:409-416.
120. Romero V., Fellows E., Jenne D.E., Andrade F. Cleavage of La protein by granzyme H induces cytoplasmic translocation and interferes with La-mediated HCV-IRES translational activity. Cell Death. Differ. 2009, 16:340-348.
121. Ronday H.K., van der Laan W.H., Tak P.P., de Roos J.A., Bank R.A., TeKoppele J.M., Froelich C.J., Hack C.E., Hogendoorn P.C., Breedveld F.C., Verheijen J.H. Human granzyme B mediates cartilage proteoglycan degradation and is expressed at the invasive front of the synovium in rheumatoid arthritis. Rheumatology (Oxford) 2001, 40:55-61.
122. Rowshani A.T., Florquin S., Bemelman F., Kummer J.A., Hack C.E., ten Berge I.J.M. Hyperexpression of the granzyme B inhibitor PI-9 in human renal allografts: a potential mechanism for stable renal function in patients with subclinical rejection. Kidney Int. 2004, 66:1417-1422.
123. Saarinen J., Kalkkinen N., Welgus H.G., Kovanen P.T. Activation of human interstitial procollagenase through direct cleavage of the Leu83-Thr84 bond by mast cell chymase. J. Biol. Chem. 1994, 269:18134-18140.
124. Sakai K., Ren S., Schwartz L.B. A novel heparin-dependent processing pathway for human tryptase. Autocatalysis followed by activation with dipeptidyl peptidase I. J. Clin. Invest. 1996, 97:988-995.
125. Schechter N.M., Irani A.M., Sprows J.L., Abernethy J., Wintroub B., Schwartz L.B. Identification of a cathepsin G-like proteinase in the MCTC type of human mast cell. J. Immunol. 1990, 145:2652-2661.
126. Schick C., Kamachi Y., Bartuski A.J., Cataltepe S., Schechter N.M., Pemberton P.A., Silverman G.A. Squamous cell carcinoma antigen 2 is a novel serpin that inhibits the chymotrypsin-like proteinases cathepsin G and mast cell chymase. J. Biol. Chem. 1997, 272:1849-1855.
127. Schiemann F., Grimm T.A., Hoch J., Gross R., Lindner B., Petersen F., Bulfone-Paus S., Brandt E. Mast cells and neutrophils proteolytically activate chemokine precursor CTAP-III and are subject to counterregulation by PF-4 through inhibition of chymase and cathepsin G. Blood 2006, 107:2234-2242.
128. Schreiber A., Busjahn A., Luft F.C., Kettritz R. Membrane expression of proteinase 3 is genetically determined. J. Am. Soc. Nephrol. 2003, 14:68-75.
129. Schwartz L.B., Bradford T.R., Littman B.H., Wintroub B.U. The fibrinogenolytic activity of purified tryptase from human lung mast cells. J. Immunol. 1985, 135:2762-2767.
130. Schwartz L.B., Bradford T.R., Rouse C., Irani A.M., Rasp G., Van der Zwan J.K., Van der Linden P.W. Development of a new, more sensitive immunoassay for human tryptase: use in systemic anaphylaxis. J. Clin. Immunol. 1994, 14:190-204.
131. Scott F.L., Hirst C.E., Sun J., Bird C.H., Bottomley S.P., Bird P.I. The intracellular serpin proteinase inhibitor 6 is expressed in monocytes and granulocytes and is a potent inhibitor of the azurophilic granule protease, cathepsin G. Blood 1999, 93:2089-2097.
132. Sedelies K.A., Sayers T.J., Edwards K.M., Chen W., Pellicci D.G., Godfrey D.I., Trapani J.A. Discordant regulation of granzyme H and granzyme B expression in human lymphocytes. J. Biol. Chem. 2004, 279:26581-26587.
133. Sower L.E., Froelich C.J., Allegretto N., Rose P.M., Hanna W.D., Klimpel G.R. Extracellular activities of human granzyme A. Monocyte activation by granzyme A versus alpha-thrombin. J. Immunol. 1996, 156:2585-2590.
134. Sower L.E., Klimpel G.R., Hanna W., Froelich C.J. Extracellular activities of human granzymes. I. Granzyme A induces IL6 and IL8 production in fibroblast and epithelial cell lines. Cell Immunol. 1996, 171:159-163.
135. Spaeny-Dekking E.H., Hanna W.L., Wolbink A.M., Wever P.C., Kummer A.J., Swaak A.J., Middeldorp J.M., Huisman H.G., Froelich C.J., Hack C.E. Extracellular granzymes A and B in humans: detection of native species during CTL responses in vitro and in vivo. J. Immunol. 1998, 160:3610-3616.
136. Stack M.S., Johnson D.A. Human mast cell tryptase activates single-chain urinary-type plasminogen activator (pro-urokinase). J. Biol. Chem. 1994, 269:9416-9419.
137. Standish A.J., Weiser J.N. Human Neutrophils Kill Streptococcus pneumoniae via Serine Proteases. J. Immunol. 2009.
138. Strik M.C., de Koning P.J., Kleijmeer M.J., Bladergroen B.A., Wolbink A.M., Griffith J.M., Wouters D., Fukuoka Y., Schwartz L.B., Hack C.E., van Ham S.M., Kummer J.A. Human mast cells produce and release the cytotoxic lymphocyte associated protease granzyme B upon activation. Mol. Immunol. 2007, 44:3462-3472.
139. Strik M.C., Wolbink A.M., Wouters D., Bladergroen B.A., Verlaan A.R., Van H.I., Hijlkema S., Hack C.E., Kummer J.A. Intracellular serpin SERPINB6 (PI6) is abundantly expressed by human mast cells and forms complexes with beta-tryptase monomers. Blood 2004, 103:2710-2717.
140. Sugimoto M., Furuta T., Kodaira C., Nishino M., Yamade M., Ikuma M., Sugimura H., Hishida A. Polymorphisms of matrix metalloproteinase-7 and chymase are associated with susceptibility to and progression of gastric cancer in Japan. J. Gastroenterol. 2008, 43:751-761.
141. Taipale J., Lohi J., Saarinen J., Kovanen P.T., Keski-Oja J. Human mast cell chymase and leukocyte elastase release latent transforming growth factor-beta 1 from the extracellular matrix of cultured human epithelial and endothelial cells. J. Biol. Chem. 1995, 270:4689-4696.
142. Tak P.P., Spaeny-Dekking L., Kraan M.C., Breedveld F.C., Froelich C.J., Hack C.E. The levels of soluble granzyme A and B are elevated in plasma and synovial fluid of patients with rheumatoid arthritis (RA). Clin. Exp. Immunol. 1999, 116:366-370.
143. Taub D.D., Ortaldo J.R., Turcovski-Corrales S.M., Key M.L., Longo D.L., Murphy W.J. Beta chemokines costimulate lymphocyte cytolysis, proliferation, and lymphokine production. J. Leukoc. Biol. 1996, 59:81-89.
144. Tosi M.F., Zakem H., Berger M. Neutrophil elastase cleaves C3bi on opsonized pseudomonas as well as CR1 on neutrophils to create a functionally important opsonin receptor mismatch. J. Clin. Invest. 1990, 86:300-308.
145. Tremblay G.M., Wolbink A.M., Cormier Y., Hack C.E. Granzyme activity in the inflamed lung is not controlled by endogenous serine proteinase inhibitors. J. Immunol. 2000, 165:3966-3969.
146. Tschopp C.M., Spiegl N., Didichenko S., Lutmann W., Julius P., Virchow J.C., Hack C.E., Dahinden C.A. Granzyme B, a novel mediator of allergic inflammation: its induction and release in blood basophils and human asthma. Blood 2006, 108:2290-2299.
147. Tzortzaki E.G., Lambiri I., Vlachaki E., Siafakas N.M. Biomarkers in COPD. Curr. Med. Chem. 2007, 14:1037-1048.
148. Urata H., Kinoshita A., Misono K.S., Bumpus F.M., Husain A. Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart. J. Biol. Chem. 1990, 265:22348-22357.
149. van der Geld Y.M., Limburg P.C., Kallenberg C.G. Proteinase 3. Wegener's autoantigen: from gene to antigen. J. Leukoc. Biol. 2001, 69:177-190.
150. Voskoboinik I., Smyth M.J., Trapani J.A. Perforin-mediated target-cell death and immune homeostasis. Nat. Rev. Immunol. 2006, 6:940-952.
151. Waterhouse N.J., Trapani J.A. H is for helper: granzyme H helps granzyme B kill adenovirus-infected cells. Trends Immunol. 2007.
152. Waugh S.M., Harris J.L., Fletterick R., Craik C.S. The structure of the pro-apoptotic protease granzyme B reveals the molecular determinants of its specificity. Nat. Struct. Biol. 2000, 7:762-765.
153. Weinrauch Y., Drujan D., Shapiro S.D., Weiss J., Zychlinsky A. Neutrophil elastase targets virulence factors of enterobacteria. Nature 2002, 417:91-94.
154. Wever P.C., Boonstra J.G., Laterveer J.C., Hack C.E., van der Woude F.J., Daha M.R., ten Berge I.J.M. Mechanisms of lymphocyte-mediated cytotoxicity in acute renal allograft rejection. Transplantation 1998, 66:259-264.
155. Wever P.C., Spaeny L.H., van der Vliet H.J., Rentenaar R.J., Wolbink A.M., Surachno J., Wertheim P.M., Schellekens P.T., Hack C.E., ten Berge I.J.M. Expression of granzyme B during primary cytomegalovirus infection after renal transplantation. J. Infect. Dis. 1999, 179:693-696.
156. Wilson T.J., Nannuru K.C., Singh R.K. Cathepsin G recruits osteoclast precursors via proteolytic activation of protease-activated receptor-1. Cancer Res. 2009, 69:3188-3195.
157. Wood A.M., Stockley R.A. Alpha one antitrypsin deficiency: from gene to treatment. Respiration 2007, 74:481-492.
158. Zhang D., Beresford P.J., Greenberg A.H., Lieberman J. Granzymes A and B directly cleave lamins and disrupt the nuclear lamina during granule-mediated cytolysis. Proc. Natl. Acad. Sci. U. S. A 2001, 98:5746-5751.
159. Zhang M., Liu N., Park S.M., Wang Y., Byrne S., Murmann A.E., Bahr S., Peter M.E., Olson S.T., Belaaouaj A., shton-Rickardt P.G. Serine protease inhibitor 6-deficient mice have increased neutrophil immunity to pseudomonas aeruginosa. J. Immunol. 2007, 179:4390-4396.
160. Zhao T., Zhang H., Guo Y., Fan Z. Granzyme K directly processes bid to release cytochrome c and endonuclease G leading to mitochondria-dependent cell death. J. Biol. Chem. 2007, 282:12104-12111.
161. Zhao T., Zhang H., Guo Y., Zhang Q., Hua G., Lu H., Hou Q., Liu H., Fan Z. Granzyme K cleaves the nucleosome assembly protein SET to induce single-stranded DNA nicks of target cells. Cell Death. Differ. 2007, 14:489-499.
162. Zhu P., Martinvalet D., Chowdhury D., Zhang D., Schlesinger A., Lieberman J. The CTL protease granzyme A cleaves and inactivates PARP-1. Blood 2009.
163. Zorn B., Virant-Klun I., Meden-Vrtovec H. Semen granulocyte elastase: its relevance for the diagnosis and prognosis of silent genital tract inflammation. Hum. Reprod. 2000, 15:1978-1984.